`
Wednesday, 16 August 2017

Japan News

  • Aortic stent grafts market to grow at slow pace'

    Japan |  Analysis | By BioSpectrum Bureau | 0 Comment | 17 Oct, 2014

    Singapore: The global aortic stent grafts market will increase in value from an estimated $1.2 billion in 2013 to just over $1.9 billion by 2020, representing a compound annual growth rate ...Read more

  • Japanese medical firms enter into the Philippines

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 02 Jan, 2015

    Singapore: With a view to expand into the lucrative Asian markets, two major medical companies in Japan have planned to set up manufacturing facilities at the First Philippine Industrial Pa...Read more

  • Nihon University to host 8K Imaging Technology Symposium

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 07 Jul, 2015

    For the first time, Nihon University will organize an international symposium on Medical-Engineering Collaboration with the theme - Medicine Definitely Jumps Up with 8K - will be held on Ju...Read more

  • Novocure launches Optune in 23 brain cancer centers in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 01 Jun, 2015

    Physicians at 23 brain cancer centers in Japan are now certified to provide Optune to recurrent glioblastoma patients on prescription order. US-based Novocure, a commercial stage oncology c...Read more

  • Serendex signs $11.5 million-worth deal with an undisclosed Japanese company

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 21 Dec, 2015

    Norway-based Serendex Pharmaceuticals A/S has entered into a non-binding term sheet with a pharma company regarding Serendex's possible future grant of an exclusive license to the compound ...Read more

  • Plasticell appoints Veritas as the exclusive distributor

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2012

    Singapore: Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has engaged Veritas of Tokyo as the exclusive distribu...Read more

  • OphthaliX secures patent from Japan for intraocular pressure therapeutic

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 21 Dec, 2015

    OphthaliX Inc., a clinical-stage company focused on developing therapeutic products for the treatment of ophthalmic disorders and a subsidiary of New York's Can-Fite BioPharma Ltd., announc...Read more

  • Sigma-Aldrich, Tokyo university develop microRNA

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 14 Feb, 2013

    Singapore: Sigma-Aldrich's innovative biological products and services business Sigma Life Science signed an exclusive collaboration with Dr Hideo Iba and Dr Takeshi Haraguchi at the Univer...Read more

  • Sun Pharma enters Japanese prescription market

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 30 Mar, 2016

    Singapore: Sun Pharma has announced the acquisition of 14 established prescription brands from Novartis AG and Novartis Pharma AG (together 'Novartis') in Japan. According to the agreement...Read more

  • Japan Okays Sanofi's Basal Insulin Drug

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 06 Jul, 2015

    French pharma giant Sanofi has announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing authorization for insulin glargine [rDNA origin] injection, 300...Read more

  • NextDocs expands customer list by more than 10%

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013

    Singapore: NextDocs, the global leader in compliance solutions for regulated industries, announced that it has expanded its client roster by more than 10 percent over the past six months, a...Read more

  • ReSearch, Asklep JV to offer CRO services in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 28 Mar, 2013

    ‎Singapore: ReSearch Pharmaceutical Services (RPS) and Japan-based Asklep have formed a joint venture company (JVC) to deliver leading-edge R&D outsourcing solutions in Japan to t...Read more

  • Nipro strengthens US business with Infraredx acquisition

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 14 Sep, 2015

    Tokyo: Nipro Corporation, headquartered in Osaka, Japan, has signed a definitive agreement to acquire US headquartered Infraredx Inc., an intravascular imaging company committed to advanci...Read more

  • Eisai, Purdue to co-develop insomnia drug

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2015

    Singapore: The US arm of Japan's Eisai has entered into a worldwide collaboration with Purdue Pharma to develop and commercialize Eisai's clinical candidate lemborexant, a dual orexin recep...Read more

  • Investment arm of Dentsu invests in Cue's at-home health tracker

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 30 Dec, 2015

    Tokyo-headquartered Dentsu Inc announced that the company's corporate venture capital arm Dentsu Ventures Global Fund has made an investment in Cue Inc. Cue Inc is a US technology company ...Read more

  • Eisai seeks simultaneous approval for anticancer agent in Japan, US and Europe

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2015

    Japanese pharmaceutical major Eisai Co. Ltd. has submitted applications to regulatory authorities in Japan, United States and Europe (MHLW, FDA and EMA respectively) seeking an additional i...Read more

  • Astellas, ClearPath to enter strategic partnership

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 06 Jan, 2014

    Singapore: Astellas Pharma and ClearPath Development Company have announced a strategic partnership to form a portfolio of development companies focused on vaccines targeting infectious dis...Read more

  • Eisai publishes phase III results of anti-seizure drug

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 26 Jul, 2012

    Singapore: Eisai published the results of its 'adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304' online in the July 25, 2012, edition of Neurology...Read more

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls